Spero Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Spero Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Spero Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.33 USD/shares, a 43.5% decline year-over-year.
  • Spero Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was 0.34 USD/shares, a 100% increase year-over-year.
  • Spero Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was 0.43 USD/shares.
  • Spero Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.23 USD/shares, a 57.7% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0.34 $0 $0 -43.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $0.44 $0 +$0.01 +4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $0.43 $0.97 $0 -1.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $0.44 $0 +$0.27 +81.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0.17 $0 +$0.64 +73.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $0 $0 +$0.76 +75.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$1 $0.98 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $0 +$0.37 +52.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1 $0 -38.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.